A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans

The cannabinoid CB1 receptor is a well-known player in energy homeostasis and its specific antagonism has been used in clinical practice for the treatment of obesity. The G protein-coupled receptor GPR55 has been recently proposed as a new cannabinoid receptor and, by contrast, its pharmacology is s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of endocrinology 2011-11, Vol.211 (2), p.177-185
Hauptverfasser: Romero-Zerbo, Silvana Y, Rafacho, Alex, Díaz-Arteaga, Adenis, Suárez, Juan, Quesada, Ivan, Imbernon, Mónica, Ross, Ruth A, Dieguez, Carlos, Rodríguez de Fonseca, Fernando, Nogueiras, Rubén, Nadal, Ángel, Bermúdez-Silva, Francisco J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The cannabinoid CB1 receptor is a well-known player in energy homeostasis and its specific antagonism has been used in clinical practice for the treatment of obesity. The G protein-coupled receptor GPR55 has been recently proposed as a new cannabinoid receptor and, by contrast, its pharmacology is still enigmatic and its physiological role is largely unexplored, with no reports investigating its putative role in metabolism. Thus, we aim to investigate in rats the presence, distribution and putative physiological role of GPR55 in a key metabolic tissue, the endocrine pancreas. We found high Gpr55 mRNA content in pancreatic islets and considerable protein distribution in insulin-secreting β-cells. Activation of GPR55 by the agonist O-1602 increased calcium transients (P
ISSN:0022-0795
1479-6805
DOI:10.1530/JOE-11-0166